Company:  CAMBREX CORP (CBM)
Form Type:  8-K
Filing Date:  8/10/2018 
CIK:  0000820081 
Address:  ONE MEADOWLANDS PLZ 
City, State, Zip:  E RUTHERFORD, New Jersey 07073 
Telephone:  (201) 804-3000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$39.01  
Change: 
-0.44 (-1.12%)  
Trade Time: 
Mar 19  
Market Cap: 
$1.31B
Trade CBM now with 

© 2019  
Description of Business
Cambrex Corporation (the "Company" or "Cambrex"), a Delaware corporation, began business in December 1981. Cambrex is a life sciences company that provides products and services that accelerate and improve the development and commercialization of new and generic therapeutics. The Company primarily supplies its products and services worldwide to innovator and generic pharmaceutical companies. The Company's overall strategy is to: grow its portfolio of custom development projects, especially those in the later stages of the clinical trial process; secure long-term supply agreements to produce active pharmaceutical ingredients ("APIs") and intermediates for newly approved drug products; expand sales of products and projects based on its proprietary technologies. With the acquisition of Halo Pharma ("Halo"), the Company has added capabilities as a finished dosage form Contract Development and Manufacturing Organization.
Register and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.02. Departure of Directors or Certain Officers; ...
    SIGNATURES